BNP Paribas Exane reiterates ServiceNow stock Outperform rating By Investing.com

BNP Paribas Exane reiterated an Outperform on ServiceNow with a $140 price target, implying ~23% upside from the current $113.62; Citizens set a $260 target. ServiceNow emphasized AI in its latest earnings, reporting Now Assist ACV of $600M (projected to $1B by 2026) and launching two AI products (Autonomous Workforce and EmployeeWorks); it also secured FedRAMP Moderate authorization for Moveworks. Executives including CEO William R. McDermott canceled planned share sale programs per an SEC filing, a governance move likely aimed at supporting investor confidence.

Analysis

The immediate second-order winners are infrastructure and compute providers: sustained rollout of enterprise AI workflows materially raises demand for GPU/accelerator cycles and cloud hosting, shifting opex from SaaS gross margins to hyperscaler bills over the next 6–18 months unless vendors renegotiate pass-through pricing. That dynamic benefits select hardware and cloud vendors (directly monetizing inference/training demand) and benefits specialist system integrators and observability vendors who capture implementation and monitoring fees as customers stitch models into production.

On the competitive front, workflow automation incumbents with deep platform hooks (custom objects, approval flows, identity integration) gain stickiness faster than point-solution AI startups; this raises the marginal value of enterprise customer relationships versus pure-play assistants. However, commoditization risk is real—if major cloud/native stacks bundle comparable workflow automation primitives, price competition could compress ASPs and elongate payback periods, making near-term revenue beats less durable.

Key near-term catalysts to watch are measurable telemetry: ACV upsell cadence, seat expansion velocity, and cloud compute cost as a percent of subscription revenue over the next four quarters. Tail risks include a macro IT budget pullback, an AI regulatory event (discovery/accuracy liabilities) that slows procurement cycles for 6–12 months, or rapid feature parity from deep-pocketed platform vendors that forces accelerated reinvestment into R&D and sales to defend growth.

Key Decisions for Investors

• Long conviction + defined cost: buy a 12–18 month call spread on NOW (long nearer-term ATM call, sell a higher strike ~1.5x ATM) to capture upside from enterprise AI monetization while capping premium exposure; enter on any sub-8% pullback. Reward: asymmetric upside if ACV/seat expansion accelerates; risk: total premium paid (limited).
• Pair trade to remove beta: go long NOW and short CRM (equal notional) for a 6–12 month horizon to express workflow automation outperformance versus pure CRM, reducing market correlation. Reward: capture platform-led upsell premium; risk: high correlation if macro improves broadly.
• Infrastructure play: buy 6–12 month NVDA or cloud provider (AMZN/MSFT) directional exposure (calls or long shares) to capture increased LLM infer/training demand. Reward: leverage to rising compute consumption; risk: cyclical GPU inventory/shipment volatility and supply constraints.
• Tactical short/avoid: reduce exposure to small, high-multiple AI point-solution SaaS names without enterprise integrations (monitor candidate list) over 3–9 months—these face feature-bundling and margin squeeze. Reward: protect portfolio from re-rating; risk: idiosyncratic wins or M&A re-rates.